FranΓ§aisπ See the interactive version (live chart) β
For IRT Living, we replayed every analyst price target of the past 12 months and measured the real outcome: 27% were profitable, average return +4% (62 calls). At 3 months: +1% average return (39% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| JMP Securities | 13 | 23% | +4% |
| Keybanc | 10 | 30% | +9% |
| Deutsche Bank | 5 | 20% | +3% |
| RBC Capital | 5 | 40% | +4% |
| Barclays | 5 | 20% | -8% |
Is IRT Living overvalued, and is it a good time to buy IRT Living right now? If you're wondering, here's a recap to make up your own mind: IRT Living's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | IRT Living | Sector median (Real Estate) |
|---|---|---|
| P/E | 91.1 | 29.5 |
| Forward P/E | 102.5 | 34.2 |
| Net margin | 6% | 25% |
π IRT Living trades above its sector median (91.1 vs 29.5) β the market expects higher growth; watch out for disappointment.
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : IRT Living pays about $0.69/share/yr β 4.02% yield. what is this?
The analyst consensus on IRT Living (IRT) is "Buy" (10 bullish, 0 bearish calls over 12 months). This is not advice: historically, 27% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $19.00 (+16% vs $16.40), ranging from $19.00 to $20.00 (4 analysts).
Over 1 year, 27% of analyst targets on IRT Living were profitable, for an average return of +4% (across 62 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $19.00 within 12 months, i.e. +16% vs the current price. The most bullish targets $20.00, the most cautious $19.00.
Note: analyst targets are 12-month (median $19.00, +16%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (27%), and the stock's past trajectory.
Its P/E is 91.1, forward P/E 102.5. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of IRT Living β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.